\-\ Texto\\:\\ \ \(0\)\
\-\ non\\ contributory\ \(16\)\
\-\ bilateral\\ and\\ symmetric\\ subependymal\\ soft\\ tissue\\ areas\\ surround\\ the\\ lateral\\ ventricles\\ and\\ follow\\ gray\\ matter\\ signal\\ intensity\\ on\\ all\\ pulse\\ sequences\\.\ \(0\)\
\-\ subependymal\\ gray\\ matter\\ heterotopia\ \(0\)\
\-\ subependymal\\ spread\\ of\\ neoplasm\ \(0\)\
\-\ subependymal\\ hemorrhage\ \(2\)\
\-\ band\\ heterotopia\ \(1\)\
\-\ subpendymal\\ gray\\-matter\\ heterotopia\ \(0\)\
\-\ tuberous\\ sclerosis\\ \\-\\ subependymal\\ nodular\\ hamartoma\ \(0\)\
\-\ neurofibromatosis\ \(24\)\
\-\ 4\\ 1\\/2\\ year\\ old\\ who\\ presents\\ with\\ seizures\\.\\ \\ history\\ of\\ trauma\\ \\-\\ hitting\\ head\\ after\\ falling\\ backward\\ in\\ rocking\\ chair\\ 2\\ years\\ ago\\.\\ \\ head\\ ct\\ at\\ that\\ time\\ was\\ negative\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ subependymal\\:\\ 0\\.32290799729507536\ \(0\)\
\-\ heterotopia\\:\\ 0\\.21408093393488173\ \(0\)\
\-\ rocking\\:\\ 0\\.11158884080970251\ \(0\)\
\-\ gray\\:\\ 0\\.10584277052498386\ \(0\)\
\-\ subpendymal\\:\\ 0\\.10281482586590573\ \(0\)\
\-\ backward\\:\\ 0\\.10281482586590573\ \(0\)\
\-\ gray\\-matter\\:\\ 0\\.08695706677102766\ \(0\)\
\-\ chair\\:\\ 0\\.08695706677102766\ \(0\)\
\-\ matter\\:\\ 0\\.0851767081114126\ \(0\)\
\-\ hitting\\:\\ 0\\.08244219406294244\ \(0\)\
\-\ surround\\:\\ 0\\.0812357360907358\ \(0\)\
\-\ 1\\/2\\:\\ 0\\.07305058210434272\ \(0\)\
\-\ band\\:\\ 0\\.0623252927323528\ \(0\)\
\-\ head\\:\\ 0\\.06135699520440243\ \(0\)\
\-\ falling\\:\\ 0\\.061095371865850935\ \(0\)\
\-\ neurofibromatosis\\:\\ 0\\.05976169445246073\ \(0\)\
\-\ tuberous\\:\\ 0\\.05955246278219224\ \(0\)\
\-\ hamartoma\\:\\ 0\\.05914409743765779\ \(0\)\
\-\ pulse\\:\\ 0\\.05580758451521829\ \(0\)\
\-\ contributory\\:\\ 0\\.05565414957177089\ \(0\)\
\-\ spread\\:\\ 0\\.052321356922054155\ \(0\)\
\-\ ventricles\\:\\ 0\\.05088263137176907\ \(0\)\
\-\ symmetric\\:\\ 0\\.049403335926967676\ \(0\)\
\-\ seizures\\:\\ 0\\.04650449199321314\ \(0\)\
\-\ \\-\\:\\ 0\\.046372872372363635\ \(0\)\
\-\ nodular\\:\\ 0\\.045372276039391285\ \(0\)\
\-\ sequences\\:\\ 0\\.045170814579822936\ \(0\)\
\-\ non\\:\\ 0\\.04471284424339886\ \(0\)\
\-\ ago\\:\\ 0\\.040262390136674035\ \(0\)\
\-\ intensity\\:\\ 0\\.03909709716935824\ \(0\)\
\-\ sclerosis\\:\\ 0\\.0388520915623588\ \(0\)\
\-\ neoplasm\\:\\ 0\\.03683742501154339\ \(0\)\
\-\ areas\\:\\ 0\\.03639679963602616\ \(0\)\
\-\ hemorrhage\\:\\ 0\\.03600324790096247\ \(0\)\
\-\ follow\\:\\ 0\\.034369613568942206\ \(0\)\
\-\ negative\\:\\ 0\\.03230531849841613\ \(0\)\
\-\ years\\:\\ 0\\.031762571354664336\ \(0\)\
\-\ all\\:\\ 0\\.030593968220649248\ \(0\)\
\-\ time\\:\\ 0\\.030551914268852058\ \(0\)\
\-\ 4\\:\\ 0\\.030138884875684117\ \(0\)\
\-\ trauma\\:\\ 0\\.02958238964250543\ \(0\)\
\-\ signal\\:\\ 0\\.028519928231300996\ \(0\)\
\-\ who\\:\\ 0\\.02820213176128737\ \(0\)\
\-\ soft\\:\\ 0\\.026340845113842406\ \(0\)\
\-\ bilateral\\:\\ 0\\.026250857333094228\ \(0\)\
\-\ tissue\\:\\ 0\\.025638242891804983\ \(0\)\
\-\ lateral\\:\\ 0\\.023375544881323422\ \(0\)\
\-\ 2\\:\\ 0\\.023292461981146154\ \(0\)\
\-\ after\\:\\ 0\\.022379762058344334\ \(0\)\
\-\ presents\\:\\ 0\\.022096763234277544\ \(0\)\
\-\ that\\:\\ 0\\.018683300361504094\ \(0\)\
\-\ ct\\:\\ 0\\.01513042599230434\ \(0\)\
\-\ history\\:\\ 0\\.014939424527937764\ \(0\)\
\-\ at\\:\\ 0\\.014655229782678898\ \(0\)\
\-\ was\\:\\ 0\\.012509842053337808\ \(0\)\
\-\ year\\:\\ 0\\.012102598345226768\ \(0\)\
\-\ old\\:\\ 0\\.011075121479269045\ \(0\)\
\-\ on\\:\\ 0\\.009163177371714279\ \(0\)\
\-\ in\\:\\ 0\\.0053341421536741125\ \(0\)\
\-\ and\\:\\ 0\\.004557190018537176\ \(0\)\
\-\ of\\:\\ 0\\.0029494633113414793\ \(0\)\
\-\ \\.\\:\\ 0\\.001797444865688419\ \(0\)\
\-\ the\\:\\ 0\\.0017499909456155163\ \(0\)\
\-\ with\\:\\ 0\\.0014810655201251866\ \(0\)\
